Ayoobi Yazdi Niloofar, Dashti Habibollah, Batavani Nasim, Borhani Ali, Shakiba Majid, Rokni Yazdi Hadi
Department of Radiology, Tehran University of Medical Sciences, Tehran, Iran.
Department of General Surgery, Tehran University of Medical Sciences, Tehran, Iran.
J Vasc Interv Radiol. 2018 Feb;29(2):233-236. doi: 10.1016/j.jvir.2017.10.009.
This single-center prospective trial evaluated the safety and efficacy of percutaneous sclerotherapy for liver hemangiomas in 5 patients (1 man, 4 women; mean age 41.2 y) between 2016 and 2017. All patients were symptomatic (4 abdominal pain; 1 early satiety) and refused surgery. A single session of sclerotherapy with 20 cc mixture of 45 IU. Bleomycin in 10 cc distilled water and 10 cc Lipiodol (Ultra Fluide, Guerbet, France) was performed in all patients, achieving a 45.6%-71.1% lesion volume reduction and a 12.9%-41% reduction in the largest diameter of the lesion. Symptoms subsided in all patients during the 5-month follow-up period. Adverse events included a self-limited intraperitoneal hemorrhage in 1 patient.
这项单中心前瞻性试验评估了2016年至2017年间5例患者（1例男性，4例女性；平均年龄41.2岁）经皮硬化治疗肝血管瘤的安全性和有效性。所有患者均有症状（4例腹痛；1例早饱）且拒绝手术。所有患者均接受了一次硬化治疗，使用20 cc由45 IU博来霉素溶于10 cc蒸馏水和10 cc碘油（超流体，法国古博公司）组成的混合液，病变体积减少了45.6%-71.1%，病变最大直径减少了12.9%-41%。在5个月的随访期内，所有患者的症状均缓解。不良事件包括1例患者出现自限性腹腔内出血。
